Q3 FY26Published 18 Feb 2026Call held 18 Feb 2026
NEPHROPLUS Q3 FY26 Earnings Call Transcript & Analysis
Revenue₹260 cr+32% YoYAdjusted EBITDA₹63 cr+43% YoYAdjusted EBITDA Margin24.3%Adjusted PAT₹34 cr+71% YoYAdjusted PAT Margin13%
Revenue ₹260 cr (+32% YoY); Adjusted EBITDA ₹63 cr (+43% YoY); Adjusted EBITDA Margin 24.3%. Revenue for Q3 FY26 grew 32% YoY to Rs. 260 crores.
Read full transcript & analysis